- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02548884
Pancreatic Sphincterotomy Versus Double Wire Technique in Difficult Cannulation
May 18, 2021 updated by: Leena Kylanpaa, Helsinki University Central Hospital
The purpose of the study is to compare two different techniques (pancreatic sphincterotomy (PS) and double wire technique (DGW)) regarding the risk of post-ERCP pancreatitis (PEP) and the success of cannulation in difficult cannulation.
For the study, the difficult cannulation is de-fined as situation when the common bile duct has not been cannulated in five minutes, after five attempts or after two pancreatic guide wire passages or when any of those limits is exceeded.
The two techniques, the PS and the DGW, will be compared in random fashion.
The primary end-point is the risk of PEP .
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1190
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Helsinki, Finland
- Helsinki University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Naive papilla, ERCP indication common bile duct cannulation
Exclusion Criteria:
- No consent to the study
- Ongoing pancreatitis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Pancreatic sphincterotomy
Pancreatic sphincterotomy technique used in difficult biliary cannulation
|
|
Active Comparator: Double guide wire
Double guide wire technique used in difficult biliary cannulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post ERCP pancreatitis defined by ESGE guidelines published 2014
Time Frame: 48 hours
|
Acute pancreatitis within 48 hours post ERCP.
Post-ERCP pancreatitis (PEP) is defined as the presence of abdominal pain attributable to acute pancreatitis, together with a need for an unplanned hospitalization or an extension of a planned hospitalization by at least 2 days, and a serum /plasma amylase at least 3 times above the upper limit of normal at 24 hours after the procedure.
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biliary cannulation success within 15 minutes after randomization
Time Frame: 15 minutes
|
After randomization, timing to get the wire in biliary duct.
First assessed the number of procedures succeeded in 15 minutes.
|
15 minutes
|
Biliary cannulation success, total number
Time Frame: 2 hours
|
The total number of successful biliary cannulations after randomization
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
September 30, 2020
Study Completion (Actual)
December 30, 2020
Study Registration Dates
First Submitted
September 3, 2015
First Submitted That Met QC Criteria
September 11, 2015
First Posted (Estimate)
September 14, 2015
Study Record Updates
Last Update Posted (Actual)
May 20, 2021
Last Update Submitted That Met QC Criteria
May 18, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- Difficult cannulation
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endoscopic Retrograde Cholangiopancreatography
-
Indiana UniversityCompletedCholangiopancreatography, Endoscopic RetrogradeUnited States
-
Boston Scientific CorporationCompletedEndoscopic Retrograde CholangiopancreatographyUnited States, Netherlands
-
Helsinki University Central HospitalCompletedEndoscopic Retrograde CholangiopancreatographyFinland
-
Ambu A/SAmbu Inc.; Infinite Clinical Solutions; Prelude DynamicsCompletedEndoscopic Retrograde Cholangiopancreatography (ERCP)United States
-
University of California, IrvineCompletedEndoscopic Retrograde Cholangiopancreatography (ERCP) | Endoscopic Ultrasound (EUS)United States
-
Kliniken Ludwigsburg-Bietigheim gGmbHNot yet recruitingCholangiopancreatography, Endoscopic Retrograde
-
Olympus Europe SE & Co. KGTerminatedCholangiopancreatography, Endoscopic RetrogradeBelgium, Germany, Norway
-
Boston Scientific CorporationCompletedEndoscopic Retrograde CholangiopancreatographyUnited States
-
University Hospital, LinkoepingCompletedEndoscopic Retrograde CholangiopancreatographySweden
-
AdventHealthCompletedEndoscopic Retrograde CholangiopancreatographyUnited States
Clinical Trials on Biliary cannulation
-
Ajou University School of MedicineCompletedPancreatic Cancer | Bile Duct Cancer | Choledocholithiasis | Ampullary TumorKorea, Republic of
-
Helsinki University Central HospitalRecruitingEndoscopic Retrograde CholangiopancreatographyFinland
-
Duke UniversityCompletedEndoscopic Retrograde CholangiopancreatographyUnited States
-
Jessa HospitalNot yet recruiting
-
Ajou University School of MedicineCompleted
-
Azienda Usl di BolognaNiguarda Hospital; Catania Hospital GastroenterologyCompletedBiliary Tract DiseasesItaly
-
St. Jude Children's Research HospitalCompletedCannulationUnited States
-
Hospital of South West JutlandKolding SygehusActive, not recruitingEnd-stage Renal Disease (ESRD)Denmark
-
Medical University of GdanskCompleted
-
Dongliang Zhang, MDTerminatedArteriovenous FistulaChina